Alpine Global Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Alpine Global Management's BMY Position: Q4 2021 in Review
Alpine Global Management sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 4,623 shares — an estimated $274K sold.
Alpine Global Management first reported a position in BMY in Q4 2014 and held it in 6 quarters. The position peaked at $2.17M in Q4 2014. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.
- Alpine Global Management reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
- Alpine Global Management sold 4,623 Bristol-Myers Squibb shares in Q4 2021, an estimated $274K.
- Alpine Global Management first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 6 quarters.
- Alpine Global Management's Bristol-Myers Squibb position peaked at $2.17M in Q4 2014.
- 2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.
Based on Alpine Global Management's 13F filing for Q4 2021, filed 14 Feb 2022.